Valuation: Acarix AB

Market Cap 289M 30.52M 26.15M 24.46M 22.39M 42.03M 2.92B 42.58M 113M 1.47B 115M 112M 4.85B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 289M 30.52M 26.15M 24.46M 22.39M 42.03M 2.92B 42.58M 113M 1.47B 115M 112M 4.85B EV / Sales 2026 *
20.6x
EV / Sales 2027 * 9.03x
Free-Float
79.69%
Yield 2026 *
-
Yield 2027 * -
1 day+1.13%
Current month+28.44%
1 month+28.44%
3 months+19.66%
6 months-19.89%
Current year-8.05%
1 month 0.03
Extreme 0.027688
0.03
Current year 0.02
Extreme 0.0218
0.04
1 year 0.02
Extreme 0.0218
0.04
3 years 0.01
Extreme 0.009
0.07
5 years 0.01
Extreme 0.009
0.07
10 years 0.01
Extreme 0.009
0.07
Manager TitleAgeSince
Chief Executive Officer - 2024-01-31
Chief Executive Officer 62 2018-02-22
Director TitleAgeSince
Director/Board Member 61 2019-12-31
Director/Board Member 52 2024-05-13
Director/Board Member - 2024-05-13
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%0.00% - - 30.63M
-0.84%+3.92%+28.04%-29.04% 18.11B
-3.05%-7.40%-38.72%+93.72% 1.69B
-0.74%+3.08%-42.56%-80.75% 1.02B
+1.26%+0.44%-21.55%+28.94% 985M
+0.11%+0.11%+63.23%-6.33% 779M
-2.29%-1.45%-36.91%-46.86% 704M
-1.91%-12.67%-44.02%-44.74% 577M
+3.23%+2.36%-39.55%-34.64% 443M
+3.19%+6.69%+77.41%+50.00% 428M
Average +0.01%-1.00%-6.07%-7.74% 2.75B
Weighted average by Cap. -0.79%+2.19%+15.83%-19.38%

Financials

2026 *2027 *
Net sales 14M 1.48M 1.27M 1.18M 1.08M 2.04M 141M 2.06M 5.46M 71.06M 5.55M 5.43M 235M 32M 3.38M 2.89M 2.71M 2.48M 4.65M 323M 4.71M 12.48M 162M 12.69M 12.41M 537M
Net income -30.8M -3.25M -2.79M -2.61M -2.39M -4.48M -311M -4.54M -12.01M -156M -12.21M -11.95M -517M -15.3M -1.62M -1.38M -1.29M -1.19M -2.22M -155M -2.25M -5.97M -77.66M -6.07M -5.93M -257M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8

Quarterly revenue - Rate of surprise